{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:51:07Z","timestamp":1794066667462,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.antiviral.2022.105484","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T08:42:30Z","timestamp":1670488950000},"page":"105484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4337-7903","authenticated-orcid":false,"given":"Jimena","family":"P\u00e9rez-Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-4860","authenticated-orcid":false,"given":"Tirosh","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1110-1291","authenticated-orcid":false,"given":"Andrea D.","family":"Olmstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-731X","authenticated-orcid":false,"given":"Ivan","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor A.H.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0105-8269","authenticated-orcid":false,"given":"Siobhan","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"De Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-6415","authenticated-orcid":false,"given":"David E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaleigha","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9714-9228","authenticated-orcid":false,"given":"Diana","family":"Bautista-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Agafitei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Levett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-2379","authenticated-orcid":false,"given":"Genoveffa","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor F.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo I.","family":"Quintana-Bulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8897-5720","authenticated-orcid":false,"given":"Darlon I.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana R.","family":"Gubiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virayu","family":"Suthiphasilp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achara","family":"Raksat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-0675","authenticated-orcid":false,"given":"Pornphimol","family":"Meesakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaraporn","family":"Polbuppha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-1059","authenticated-orcid":false,"given":"Sarot","family":"Cheenpracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-1478","authenticated-orcid":false,"given":"Wuttichai","family":"Jaidee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwanjai","family":"Kanokmedhakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chavi","family":"Yenjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonyanoot","family":"Chaiyosang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helder Lopes","family":"Teles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-461X","authenticated-orcid":false,"given":"Angelo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-7970","authenticated-orcid":false,"given":"Pierre-Luc","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-2523","authenticated-orcid":false,"given":"Roberto G.S.","family":"Berlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surat","family":"Laphookhieo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdej","family":"Kanokmedhakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tietjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Cherkasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-8748","authenticated-orcid":false,"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-0513","authenticated-orcid":false,"given":"Ivan Robert","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-7460","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105484_bib1","series-title":"A Living WHO Guideline on Drugs for Covid-19","year":"2022"},{"key":"10.1016\/j.antiviral.2022.105484_bib2","article-title":"Potent anti-SARS-CoV-2 activity by the natural product gallinamide A and analogues via inhibition of cathepsin L","author":"Ashhurst","year":"2021","journal-title":"J. Med.Chem.acs."},{"key":"10.1016\/j.antiviral.2022.105484_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910205","article-title":"Lectin from triticum vulgaris (WGA) inhibits infection with SARS-CoV-2 and its variants of concern alpha and beta","volume":"22","author":"Auth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2022.105484_bib5","first-page":"2498","article-title":"Phellopterin-induced caspase-dependent apoptosis through PI3K\/AKT pathway inhibition in SMMC-7721 human hepatoma cells","volume":"37","author":"Bao","year":"2018","journal-title":"Am. J. Pharm."},{"key":"10.1016\/j.antiviral.2022.105484_bib6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3748\/wjg.v19.i16.2529","article-title":"Effects of Nigella sativa on outcome of hepatitis C in Egypt","volume":"19","author":"Barakat","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2022.105484_bib7","series-title":"Zika Virus Impact, Diagnosis, Control, and Models","first-page":"409","article-title":"Protein kinase C as a target in the control of viruses and implication for Zika virus","author":"Bl\u00e1zquez","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105484_bib8","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1073\/pnas.85.21.7972","article-title":"Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells","volume":"85","author":"Bowman","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2022.105484_bib9","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2666-5247(20)30008-2","article-title":"SARS-CoV-2 cellular tropism","author":"Cagno","year":"2020","journal-title":"Lancet Microbe May"},{"key":"10.1016\/j.antiviral.2022.105484_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/d41586-021-03619-8","article-title":"Beyond Omicron: what's next for COVID's viral evolution","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105484_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated coronavirus variant puts scientists on alert","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105484_bib12","doi-asserted-by":"crossref","first-page":"E5497","DOI":"10.1073\/pnas.1805046115","article-title":"Protein kinase C\u03b1 gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation","volume":"115","author":"Callender","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105484_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/np900632r","article-title":"Bafilomycins produced in culture by Streptomyces spp. isolated from marine habitats are potent inhibitors of autophagy","volume":"73","author":"Carr","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.antiviral.2022.105484_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.fitote.2016.07.007","article-title":"Two new bioactive iridoids from Rothmannia wittii","volume":"113","author":"Chaipukdee","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.antiviral.2022.105484_bib15","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.antiviral.2022.105484_bib17","series-title":"Postinfection Treatment with a Protease Inhibitor Increases Survival of Mice with a Fatal SARS-CoV-2 Infection","author":"Dampalla","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105484_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","article-title":"Identification of required host factors for SARS-CoV-2 infection in human cells","volume":"184","author":"Daniloski","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105484_bib19","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/jo4014589","article-title":"Sesterterpenoids isolated from a northeastern pacific phorbas sp","volume":"78","author":"Daoust","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.antiviral.2022.105484_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108959","article-title":"Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2","volume":"35","author":"Dittmar","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105484_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105484_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105484_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(96)00785-5","article-title":"Inhibition of protein kinase C \u03bc by various inhibitors. Inhibition from protein kinase c isoenzymes","volume":"392","author":"Gschwendt","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2022.105484_bib24","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","author":"Hacisuleyman","year":"2021","journal-title":"N. Engl.J.Med.NEJMoa"},{"key":"10.1016\/j.antiviral.2022.105484_bib25","author":"Hagen"},{"key":"10.1016\/j.antiviral.2022.105484_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2004-10-4117","article-title":"PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC","volume":"106","author":"Hampson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2022.105484_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell."},{"key":"10.1016\/j.antiviral.2022.105484_bib29","article-title":"Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir","author":"Hu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.antiviral.2022.105484_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01056-22","article-title":"Protein kinase C inhibitors reduce SARS-CoV-2 replication in cultured cells","author":"Huang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2022.105484_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00439-22","article-title":"Dual inhibition of vacuolar-ATPase and TMPRSS2 is required for complete blockade of SARS-CoV-2 entry into cells","volume":"66","author":"Icho","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105484_bib32","first-page":"133","article-title":"An update on antiviral therapy against SARS-CoV-2: how far have we come?","author":"Indari","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105484_bib33","series-title":"The Substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor in Vitro and Confer Resistance to Nirmatrelvir","author":"Jochmans","year":"2022"},{"key":"10.1016\/j.antiviral.2022.105484_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111748","article-title":"Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials","volume":"13","author":"Kawano","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.antiviral.2022.105484_bib35","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"Kedei","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2022.105484_bib36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/np9003189","article-title":"Antimalarial and cytotoxic depsidones from the fungus Chaetomium brasiliense","volume":"72","author":"Khumkomkhet","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.antiviral.2022.105484_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/BJ20121871","article-title":"Adenosine-binding motif mimicry and cellular effects of a thieno[2,3- d ]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes","volume":"451","author":"Kj\u00e6r","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2022.105484_bib38","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1158\/0008-5472.CAN-03-3511","article-title":"Protein kinase C \u03b1\/\u03b2 inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells","volume":"64","author":"Koivunen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2022.105484_bib39","first-page":"2509","article-title":"The structures of novel insecticidal macrolides: bafilomycins D and E, and oxohygrolidin","volume":"49","author":"Kretschmer","year":"1985","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.antiviral.2022.105484_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00975-21","article-title":"Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease","volume":"95","author":"Kreutzberger","year":"2021","journal-title":"J. Virol."},{"issue":"1 6","key":"10.1016\/j.antiviral.2022.105484_bib41","first-page":"1","article-title":"SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3 32","key":"10.1016\/j.antiviral.2022.105484_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","article-title":"SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105484_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/carcin\/bgt313","article-title":"Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids","volume":"35","author":"Linch","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.antiviral.2022.105484_bib44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jama.2010.1191","article-title":"Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes","volume":"304","author":"Ma","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2022.105484_bib45","series-title":"Natural Product-Derived Phytochemicals as Potential Agents against Coronaviruses: A Review","author":"Mani","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105484_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0863-y","article-title":"If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future","author":"McKee","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105484_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105484_bib48","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.3390\/md13074520","article-title":"Potential antiviral agents from marine fungi: an overview","volume":"13","author":"Moghadamtousi","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.antiviral.2022.105484_bib49","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1128\/JVI.78.14.7400-7409.2004","article-title":"Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes","volume":"78","author":"Moradpour","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2022.105484_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2022.105484_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/v13050828","article-title":"Antiviral activity exerted by natural products against human viruses","volume":"13","author":"Musarra-Pizzo","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105484_bib52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/jgv.0.001453","article-title":"SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology","volume":"101","author":"Ogando","year":"2020","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2022.105484_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002468","article-title":"Human subtilase SKI-1\/S1P is a master regulator of the HCV lifecycle and a potential host cell target for developing indirect-acting antiviral agents","volume":"8","author":"Olmstead","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105484_bib54","first-page":"1","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105484_bib55","article-title":"Rebound phenomenon after nirmatrelvir\/ritonavir treatment of coronavirus disease-2019 in high-risk persons","author":"Ranganath","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105484_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-30518-x","article-title":"Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance","volume":"13","author":"Rockett","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105484_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8070970","article-title":"Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro)","volume":"8","author":"Sayed","year":"2020","journal-title":"Microorganisms"},{"issue":"7904","key":"10.1016\/j.antiviral.2022.105484_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-04482-x","article-title":"Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2","volume":"604","author":"Schultz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105484_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113157","article-title":"The race to treat COVID-19: potential therapeutic agents for the prevention and treatment of SARS-CoV-2","volume":"213","author":"Shagufta","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105484_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","author":"Shapira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105484_bib62","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2022.105484_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn7842","article-title":"Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses","author":"Sievers","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105484_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2006.00001.x","article-title":"Bryostatin-1: pharmacology and therapeutic potential as a CNS drug","volume":"12","author":"Sun","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.antiviral.2022.105484_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009929","article-title":"In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2","volume":"17","author":"Szemiel","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105484_bib66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMc2207519","article-title":"Efficacy of antibodies and antiviral drugs against omicron BA.2.12.1, BA.4, and BA.5 subvariants","volume":"387","author":"Takashita","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105484_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00181","article-title":"What is synergy? The Saariselk\u00e4 agreement revisited","volume":"6","author":"Tang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105484_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100045","article-title":"Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside","volume":"2","author":"Tao","year":"2021","journal-title":"Curr. Res.Pharmacol. Drug Discov."},{"key":"10.1016\/j.antiviral.2022.105484_bib69","series-title":"United States - COVID-19 Overview - Johns Hopkins [WWW Document]","year":"2022"},{"key":"10.1016\/j.antiviral.2022.105484_bib71","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/acs.jnatprod.1c01225","article-title":"Ansellone J, a potent in vitro and ex vivo HIV-1 latency reversal agent isolated from a phorbas sp. marine sponge","volume":"85","author":"Wang","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.antiviral.2022.105484_bib72","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1021\/acs.joc.6b02312","article-title":"Sesterterpenoids isolated from the sponge phorbas sp. activate latent HIV-1 provirus expression","volume":"81","author":"Wang","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.antiviral.2022.105484_bib73","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/md12042019","article-title":"Potential anti-HPV and related cancer agents from marine resources: an overview","volume":"12","author":"Wang","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.antiviral.2022.105484_bib74","article-title":"Turning the tide: natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105484_bib75","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1016\/S0040-4039(99)01495-1","article-title":"Holyrines A and B, possible intermediates in staurosporine biosynthesis produced in culture by a marine actinomycete obtained from the North Atlantic Ocean","volume":"40","author":"Williams","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.antiviral.2022.105484_bib76","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1080\/14786419.2018.1493583","article-title":"Terretonin D1, a new meroterpenoid from marine-derived Aspergillus\u00ef\u00bf\u00bfterreus ML-44","volume":"33","author":"Wu","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.antiviral.2022.105484_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00146","article-title":"Protein kinase C-\u03b4 mediates shedding of angiotensin-converting enzyme 2 from proximal tubular cells","volume":"7","author":"Xiao","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105484_bib78","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An infectious cDNA clone of SARS-CoV-2","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105484_bib79","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.antiviral.2022.105484_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays | enhanced reader [WWW document]","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2022.105484_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","article-title":"SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells","volume":"11","author":"Zhao","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105484_bib82","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","author":"Zheng","year":"2022","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.antiviral.2022.105484_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41467-021-21213-4","article-title":"A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1016\/j.antiviral.2023.105577","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000}}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T03:25:01Z","timestamp":1711596301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":78,"alternative-id":["S0166354222002534"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105484","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.antiviral.2023.105577","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105484"}}